Related Experiment Video
Updated: May 31, 2026

Evaluation of the Effectiveness of Longitudinal Incision for Endoscopic Submucosal Excavation of Gastric Subepithelial Lesions
Published on: April 28, 2026
Comprehensive clinicopathological analysis of sloughing esophagitis: A large single-center series
1Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Abstract:
Sloughing esophagitis (SE), a. k.a. Esophagitis dissecans superficialis, is a desquamative disorder of the esophagus characterized by superficial squamous cell layer sloughing with normal underlying mucosa. The etiology is poorly understood. We collected 72 SE cases spanning 15 years from our health system and investigated their clinicopathological features. Endoscopic findings of SE usually included characteristic sloughed mucosa with strips or ribbon-like mucosal breaks, though rare cases had normal upper endoscopy. Histologically, there was two-toned appearance with superficial parakeratosis in all cases. In our study, while the majority of SE (57%) were completely devoid of inflammation, 43% of them exhibited neutrophilic/lymphocytic inflammation (2 were severe). Fifty-seven patients (79%) were taking 5 or more prescriptions, most commonly NSAIDs and/or antiplatelets/anticoagulants (39%). Twenty patients (28%) had malignancy, and additional eleven patients (15%) were on immunosuppressive therapy. Although the precise pathogenesis of SE is unknown, it appears that it was associated with polypharmacy, malignancy, and/or immunosuppression. Acid suppressants were prescribed as the treatment for 83% SE patients. Most patients resolved at follow-up. The presence of inflammation at initial biopsy does not appear to be related to any identifiable etiology or clinical outcome.
More Related Videos
05:57Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues
Published on: May 30, 2025
03:05Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
Related Concept Videos
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Peptic Ulcer Disease III: Clinical Manifestations and Complications